Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

By Kupelian P.A.   Elshaikh M.   Reddy C.A.   Zippe C.   Klein E.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 308-309

Elsevier

Access to resources Recommend Favorite

18F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer

By    

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 316-322

Spandidos Publications

Access to resources Recommend Favorite

Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database

By Moul J.W.   Sun L.   Wu H.   McLeod D.G.   Amling C.   Lance R.   Foley J.   Sexton W.   Kusuda L.   Chung A.   Soderdahl D.   Donahue T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 447-455

Elsevier

Access to resources Recommend Favorite

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy

By                    

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 819-824

Spandidos Publications

Access to resources Recommend Favorite

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen >=40 ng/mL*

By Vanasupa B.P.   Paquette E.L.   Wu H.   Sun L.   McLeod D.G.   Moul J.W.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 4, 2002-07 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite